MILAN – Survodutide, an investigational dual glucagon-like peptide 1 (GLP-1) and glucagon receptor agonist, led to ‘exceptional improvement in disease activity and fibrosis&rsq… Read More

An investor, who purchased shares of Akero Therapeutics, Inc. (NASDAQ: AKRO), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Fe… Read More

In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. While it isn’t known whether 2024 might beat that record, it will surely be… Read More

If there’s one thing that can quickly send a healthcare stock soaring, it’s the approval of a key drug. Not only can that give investors confidence in a business’s abil… Read More

A daily low-dose aspirin pill may reduce liver fat levels in people with nonalcoholic steatohepatitis, a common chronic condition also called fatty liver disease, a new study suggests. T… Read More

Context: Madrigal Pharmaceuticals Inc.’s drug Rezdiffra gained the first US approval to treat a potentially deadly liver disease called nonalcoholic steatohepatitis, or NASH that affec… Read More

After a long list of failures, a much-awaited treatment for noncirrhotic non-alcoholic steatohepatitis (NASH), recently renamed metabolic dysfunction-associated steatohepatitis (MASH), has f… Read More

In the face of rising obesity rates, nonalcoholic fatty liver disease (NAFLD) has emerged as a silent epidemic, affecting millions worldwide. This chronic condition, characterized by the acc… Read More

With the rising prevalence of metabolic disorders, the rapid emergence of various types of novel therapeutic agents has been the need of hour. Amongst all the recently available anti-obesit… Read More

Wilmington, Delaware, United States, 2024-Mar-01 — /EPR Network/ — Nonalcoholic steatohepatitis (NASH) represents a significant and growing public health concern worldwide, chara… Read More

Metabolic dysfunction–associated steatotic liver disease (MASLD) is the accumulation of fat in the liver caused by a buildup of fat in the body. It’s a chronic liver disease… Read More

What Can Cause Alt To Be Elevated – Authors: Eric Sulawa, MD (EM Resident at Naval Medical Center Portsmouth) and Samuel Bergin, MD (EM Resident at University of Southern Nevada Medica… Read More

Fatty liver disease, encompassing nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), has emerged as a prevalent health concern in modern… Read More

Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults af… Read More

Key Highlights:  Importance of liver health and its functions.  Nutrition essentials for liver function improvement.  Lifestyle changes with potential benefit to liv… Read More

Inhalable sensors could enable early lung cancer detection. The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible w… Read More

Eli Lily and Novo Nordisk, two pharmaceutical giants in the diabetes and obesity treatment market, have recently revealed their ambitious plans to expand their offerings to include comprehen… Read More

Stocks have rallied this week, with the major averages headed for their seventh straight week in the green, and investors are betting this momentum will continue moving forward. The S &am… Read More

DURECT ( NASDAQ:DRRX – Get Free Report ) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to client… Read More

What Is The Cause Of Enlarged Liver – The liver usually contains some fat, but excess fat accumulation can cause fatty liver disease. Fatty liver disease can reduce liver function and… Read More

The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing interest in peptides for the treatmen… Read More

Key Highlights:  Cirrhosis is the severe scarring of the liver due to various factors, including alcohol abuse, hepatitis, and nonalcoholic fatty liver disease.  Symptoms can… Read More

The proposed business combination will bolster Alfasigma’s gastrointestinal and hepatology portfolio. Credit: Peakstock / Shutterstock.com. Italian company Alfasigm… Read More

Let’s talk about one of the most pressing questions in the realm of obesity: what is the most common health condition associated with it? Obesity is a growing concern worldwide, affect… Read More

Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent and potentially serious liver condition that affects millions of people worldwide. Wh… Read More

Recently, there has been a significant development on the horizon in the field of liver disease research. Scientists have identified a potential new treatment that holds the potential to tr… Read More

Share Germany’s Boehringer Ingelheim said on Thursday it would conduct three late-stage studies for its obesity drug candidate after it showed up to 19% weight loss after 46 w… Read More

Fat build up in the liver of individuals with non-alcoholic fatty liver disease (NAFLD), a syndrome that affects those who consume little to no alcohol. Up to 25% of persons in the US are af… Read More

Understanding the close interaction between Non-Alcoholic Fatty Liver Disease & Type 2 Diabetes, and continuously evolving evidence, the American Diabetes Association (ADA) has recently… Read More

 Bariatric surgery: By preventing morbidly obese people from overeating, bariatric surgery Islamabad helps them lose weight. This is carried out by reducing the intestine and stomach. B… Read More